$44.79
N/A
Last update: Nov 5, 4:00 PM
Enliven Therapeutics Inc
ELVNNASDAQ
Enliven Therapeutics (ELVN) earnings history, EPS estimates, revenue forecasts and company guidance.
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.55 | $-0.52 | $-0.56 |
| Revenue | |||
| Consensus | — | — | — |
